The global hemophilia treatment market is witnessing steady growth, driven by advancements in biotechnology, rising awareness, and improved access to treatment options. According to market insights, the hemophilia treatment market size in 2021 stood at US$ 14.44 billion and is projected to reach US$ 23.53 billion by 2031. The market is expected to register a CAGR of 5.1% during 2023–2031....